Clinical Trials Directory

Trials / Completed

CompletedNCT01407432

Impact of Folates in the Care of the Male Infertility

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
162 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Unexplained male infertility is increasing, and, nowadays, the investigators only can propose palliative treatment, as In VITRO Fertilization (IVF). The folate metabolism is a key for the maintenance of genome integrity. A dysfunction in this pathway can be responsible of spermatogenesis defects, and further, of infertility. Few assays have shown that folate treatment can improve sperm parameters and fertility, till 30% in some of theses studies. The purpose of the investigators study is to demonstrate the impact of folates treatment on improvement of sperm parameters and on the rate of success of in VITRO fertilization procedures.

Detailed description

The folate impact in the treatment of male infertility will be reviewed by this large multicentric randomized controlled double-blind study comparing 2 parallel groups of 184 patients. In each group: folic acid 15mg/day versus placebo, orally for at least 3 months (duration of a cycle of spermatogenesis). This assay will evaluate the effectiveness of treatment with folic acid compared to its placebo in infertile men with the outcome of IVF+/-ICSI techniques (pregnancy rate). It will also assess the impact of folate therapy on sperm parameters, and further, the impact on abnormal sperm DNA methylation profiles.

Conditions

Interventions

TypeNameDescription
DRUGFolic acidTaking of folic acid 15 mg per day by hanging oral route during 3 at 4 months
DRUGplacebo of folic acidTaking of placebo of folic acid by hanging oral route during 3 at 4 months

Timeline

Start date
2011-11-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2011-08-02
Last updated
2016-06-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01407432. Inclusion in this directory is not an endorsement.